Skip to main content
Premium Trial:

Request an Annual Quote

Pall Opens Proteomics Facility in Bangalore

 NEW YORK, March 21 (GenomeWeb News) - P

all has opened a Center of Excellence in Bangalore, India, the company said today. The center will include a process proteomics lab for chromatography and down-stream systems and will offer clients validation services for FDA approval.

 

“The process proteomics facility is a service to our customers, said Holly Haughney, vice president of Pall BioPharmaceuticals Marketing Asia. “In addition we will have a training facility because while there is a very well-educated technical force [in India], we’ve found that much of it is theoretical.”

 

Haughney recently relocated to the Bangalore office, along with Vinay Joban, general manager of Pall Life Sciences India.

 

Pall’s biopharm business in Asia grew by 14 percent over the last fiscal year, the company said in a statement.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.